NYT
Se kdo spomni nekaj dni stare zgodbe o tem, kako so mešetarji s cukrom kupili znanstvenike, da so polemiko o srčno-žilnih boleznih usmerili v maščobe. Pa zaključka, da je bilo to možno v šestdesetih in da je zdaj čisto drugače? Ja, evo, kako drugače:

EpiPen Maker Mylan Quietly Steers Effort to Protect Its Price
Against a growing outcry over the surging price of EpiPens, a chorus of prominent voices has emerged with a smart-sounding solution: Add the EpiPen, the lifesaving allergy treatment, to a federal list of preventive medical services, a move that would eliminate the out-of-pocket costs of the product for millions of families — and mute the protests.
Dr. Leonard Fromer, a clinical professor of family medicine at the University of California, Los Angeles, just promoted the idea in the prestigious American Journal of Medicine.
The journal article says it was “drafted and revised” by a medical writing consulting firm paid by Mylan, in consultation with Dr. Fromer. And Dr. Fromer himself has served in the last year as a paid Mylan consultant — which he discloses as part of the journal article. The company has also contributed money to many other groups behind the effort, and it has met with them — and Ms. Winders’s organization in particular — to coordinate its strategy, the participants said.
nyti.ms/2cecEKI